From: Identification of prognostic factors and surgical indications for metastatic gastric cancer
Variable | Median survival (months) | p value |
---|---|---|
Age (years) | 0.362 | |
>65 | 13.4 | |
< 65 | 13.1 | |
Sex | 0.583 | |
Female | 11.1 | |
Male | 14.2 | |
PS | < 0.001 | |
0, 1, 2 | 14.2 | |
3 | 2.4 | |
Body mass index (kg/m2) | 0.242 | |
< 21 | 11.1 | |
>21 | 14.9 | |
Hb (g/dL) | 0.428 | |
< 12 | 13.4 | |
>12 | 13.1 | |
NLR | < 0.001 | |
< 3.1 | 16.5 | |
>3.1 | 8.2 | |
CRP (mg/dL) | 0.005 | |
< 0.2 | 15.4 | |
>0.2 | 9.8 | |
Alb (g/dL) | < 0.001 | |
< 3.5 | 6.7 | |
>3.5 | 15.6 | |
CEA (ng/mL) | 0.052 | |
< 6 | 14.2 | |
>6 | 9.7 | |
CA19-9 (U/mL) | 0.003 | |
< 37 | 15.3 | |
>37 | 9.7 | |
Tumor location in stomach | 0.267 | |
Upper | 13.4 | |
Middle | 12.3 | |
Lower | 14.2 | |
Whole | 7.4 | |
Histological differentiation | 0.829 | |
Differentiated | 14.6 | |
Undifferentiated | 11.4 | |
Adjacent organ invasion | 0.009 | |
Yes | 7.8 | |
No | 14.6 | |
Bulky lymph nodes | 0.011 | |
Yes | 9.3 | |
No | 12.5 | |
Metastasis to organs | 0.044 | |
1 organ | 15.4 | |
≥2 organs | 10.1 | |
Peritoneal metastasis | 0.174 | |
Present | 11.1 | |
Absent | 16.2 | |
Hepatic metastasis | 0.556 | |
Present | 15.3 | |
Absent | 11.4 | |
Distant lymph node metastasis | 0.117 | |
Present | 10.1 | |
Absent | 14.6 | |
Gastrectomy | < 0.0001 | |
Present | 15.6 | |
Absent | 7.2 | |
Chemotherapy | 0.007 | |
Yes | 14.4 | |
No | 4.7 |